A Minimally Invasive Technique Using Acellular Dermal Matrix Versus De-Epithelialized Free Gingival Graft in The Treatment of Type I Gingival Recession (Randomized Controlled Clinical Trial)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202507533761097

Enrollment

Registered

2025-07-17

Start date

2024-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health

Interventions

De epithelialized Free gingival graft

A cellular dermal matrix

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Gingival recession type 1 according to Cairo et al (2011). Adequate amount of attached gingiva (AG) (2 mm= AG). Good oral hygiene (full mouth bleeding score of 0 and O’Leary index less than =10 % after complete phase I therapy) Clinically thick gingival biotype (gingival thickness >1mm ). Anterior esthetic zone or premolar area.

Exclusion criteria

Exclusion criteria: Uncooperative patients Smoking more than 10 cigarettes per day Patients with Diabetes , sever hypertension or coronally insufficiently Pregnant and lactating women. Patients with traumatic occlusion.

Design outcomes

Primary

Measure	Time frame
Recession depth ;Clinical attachment level	—

Secondary

Measure	Time frame
Gingival thickness	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026